Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
1.620
-0.180 (-10.00%)
Apr 19, 2024, 3:46 PM EDT - Market open

Bone Biologics Statistics

Total Valuation

Bone Biologics has a market cap or net worth of $1.43 million. The enterprise value is -$1.35 million.

Market Cap 1.43M
Enterprise Value -1.35M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

Bone Biologics has 879,175 shares outstanding. The number of shares has increased by 452.14% in one year.

Shares Outstanding 879,175
Shares Change (YoY) +452.14%
Shares Change (QoQ) -32.84%
Owned by Insiders (%) 8.15%
Owned by Institutions (%) 1.26%
Float 480,932

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.58
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.50, with zero debt.

Current Ratio 4.50
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -236.00% and return on invested capital (ROIC) is -324.40%.

Return on Equity (ROE) -236.00%
Return on Assets (ROA) -154.80%
Return on Capital (ROIC) -324.40%
Revenue Per Employee n/a
Profits Per Employee -$4.47M
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -97.17% in the last 52 weeks. The beta is 0.58, so Bone Biologics's price volatility has been lower than the market average.

Beta (1Y) 0.58
52-Week Price Change -97.17%
50-Day Moving Average 2.47
200-Day Moving Average 4.92
Relative Strength Index (RSI) 38.78
Average Volume (30 Days) 87,680

Short Selling Information

The latest short interest is 15,106, so 1.72% of the outstanding shares have been sold short.

Short Interest 15,106
Short Previous Month 31,089
Short % of Shares Out 1.72%
Short % of Float 3.14%
Short Ratio (days to cover) 0.10

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -9.43M
Pretax Income -8.95M
Net Income -8.95M
EBITDA -8.95M
EBIT -8.95M
Earnings Per Share (EPS) -$34.01
Full Income Statement

Balance Sheet

The company has $3.03 million in cash and no debt, giving a net cash position of $3.03 million or $3.44 per share.

Cash & Cash Equivalents 3.03M
Total Debt n/a
Net Cash 3.03M
Net Cash Per Share $3.44
Equity / Book Value 2.91M
Book Value Per Share 3.31
Working Capital 2.91M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.56M
Capital Expenditures n/a
Free Cash Flow -9.56M
FCF Per Share -$36.32
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Bone Biologics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -452.14%
Shareholder Yield -452.14%
Earnings Yield -534.11%
FCF Yield -570.35%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 20, 2023. It was a reverse split with a ratio of 1:8.

Last Split Date Dec 20, 2023
Split Type Reverse
Split Ratio 1:8

Scores

Altman Z-Score n/a
Piotroski F-Score 1